Qingchun Mu[Author] - Search Results

Year	Number of Results
2010	2
2014	1
2015	6
2016	5
2017	1
2018	3
2020	3
2021	8
2022	7
2023	3
2024	4

1

Ligustrazine Nanoparticle Hitchhiking on Neutrophils for Enhanced Therapy of Cerebral Ischemia-Reperfusion Injury.

Mu Q, Yao K, Syeda MZ, Zhang M, Cheng Q, Zhang Y, Sun R, Lu Y, Zhang H, Luo Z, Huang H, Liu X, Luo C, Zhu X, Wu S, Cui L, Huang C, Chen X, Tang L. Mu Q, et al. Adv Sci (Weinh). 2023 Jul;10(19):e2301348. doi: 10.1002/advs.202301348. Epub 2023 Apr 20. Adv Sci (Weinh). 2023. PMID: 37078794 Free PMC article.

2

Ligustrazine monomer against cerebral ischemia/reperfusion injury.

Gao HJ, Liu PF, Li PW, Huang ZY, Yu FB, Lei T, Chen Y, Cheng Y, Mu QC, Huang HY. Gao HJ, et al. Neural Regen Res. 2015 May;10(5):832-40. doi: 10.4103/1673-5374.156991. Neural Regen Res. 2015. PMID: 26109963 Free PMC article. Review.

3

Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment.

Tang L, Feng Y, Gao S, Mu Q, Liu C. Tang L, et al. Among authors: mu q. Front Pharmacol. 2021 Nov 25;12:786700. doi: 10.3389/fphar.2021.786700. eCollection 2021. Front Pharmacol. 2021. PMID: 34899350 Free PMC article. Review.

4

Intracranial hemorrhage after spinal surgery: a literature review.

Huang H, Zhu C, Qin H, Deng L, Huang C, Saifi C, Bondar K, Giordan E, Danisa O, Chung JH, Elgafy H, Fonseka RD, Huang C, Mu Q. Huang H, et al. Among authors: mu q. Ann Transl Med. 2022 Oct;10(20):1141. doi: 10.21037/atm-22-4929. Ann Transl Med. 2022. PMID: 36388815 Free PMC article. Review.

5

Natural products as LSD1 inhibitors for cancer therapy.

Fang Y, Yang C, Yu Z, Li X, Mu Q, Liao G, Yu B. Fang Y, et al. Among authors: mu q. Acta Pharm Sin B. 2020 Jun 20;11(3):621-31. doi: 10.1016/j.apsb.2020.06.007. Online ahead of print. Acta Pharm Sin B. 2020. PMID: 32837872 Free PMC article. Review.

6

Targeting Neutrophils for Enhanced Cancer Theranostics.

Tang L, Wang Z, Mu Q, Yu Z, Jacobson O, Li L, Yang W, Huang C, Kang F, Fan W, Ma Y, Wang M, Zhou Z, Chen X. Tang L, et al. Among authors: mu q. Adv Mater. 2020 Aug;32(33):e2002739. doi: 10.1002/adma.202002739. Epub 2020 Jul 12. Adv Mater. 2020. PMID: 32656801

7

Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors.

Mu Q, Lv Y, Luo C, Liu X, Huang C, Xiu Y, Tang L. Mu Q, et al. Front Pharmacol. 2021 Sep 9;12:709324. doi: 10.3389/fphar.2021.709324. eCollection 2021. Front Pharmacol. 2021. PMID: 34566636 Free PMC article. Review.

8

Neutrophil Targeting Platform Reduces Neutrophil Extracellular Traps for Improved Traumatic Brain Injury and Stroke Theranostics.

Mu Q, Yao K, Syeda MZ, Wan J, Cheng Q, You Z, Sun R, Zhang Y, Zhang H, Lu Y, Luo Z, Li Y, Liu F, Liu H, Zou X, Zhu Y, Peng K, Huang C, Chen X, Tang L. Mu Q, et al. Adv Sci (Weinh). 2024 Mar 23:e2308719. doi: 10.1002/advs.202308719. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38520727

9

Research progress on the mechanism of action of hesperetin in cerebral ischemia: a narrative review.

Mu Q, Zhang Y, Cheng Q, Huang H, Huang C, Tang L. Mu Q, et al. Ann Transl Med. 2022 Jul;10(14):806. doi: 10.21037/atm-22-3136. Ann Transl Med. 2022. PMID: 35965833 Free PMC article. Review.

10

Engineered Polymer Nanoplatforms for Targeted Tumor Cells and Controlled Release Cargos to Enhance Cancer Treatment.

Wang Z, Tang L, Mu Q, Che S, Sun Y, Bai L, Luo Y, Yang Y, Yu M, Yu Z. Wang Z, et al. Among authors: mu q. Curr Med Chem. 2021;28(31):6395-6410. doi: 10.2174/0929867328666210226143148. Curr Med Chem. 2021. PMID: 33634752 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

42 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year